BlackRock Institutional Trust’s Bristol-Myers Squibb BMY Stock Holding History

BlackRock Institutional Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.69B	Sell	46,068,321 -908,927	-2%	-$49.7M	0.4%	41
2016 Q3	$2.53B	Buy	46,977,248 +2,517,496	+6%	+$162M	0.39%	46
2016 Q2	$3.27B	Sell	44,459,752 -282,432	-0.6%	-$20M	0.53%	32
2016 Q1	$2.86B	Buy	44,742,184 +844,233	+2%	+$53.2M	0.47%	38
2015 Q4	$3.02B	Buy	43,897,951 +238,706	+0.5%	+$15.8M	0.5%	35
2015 Q3	$2.58B	Buy	43,659,245 +106,371	+0.2%	+$6.75M	0.45%	38
2015 Q2	$2.9B	Sell	43,552,874 -798,634	-2%	-$52.6M	0.47%	39
2015 Q1	$2.86B	Buy	44,351,508 +919,816	+2%	+$57.6M	0.45%	40
2014 Q4	$2.56B	Sell	43,431,692 -69,750	-0.2%	-$3.93M	0.41%	41
2014 Q3	$2.23B	Sell	43,501,442 -1,359,816	-3%	-$67.9M	0.37%	45
2014 Q2	$2.18B	Buy	44,861,258 +555,006	+1%	+$27.4M	0.36%	45
2014 Q1	$2.3B	Buy	44,306,252 +2,129,645	+5%	+$113M	0.4%	40
2013 Q4	$2.24B	Sell	42,176,607 -1,328,005	-3%	-$67.6M	0.4%	44
2013 Q3	$2.01B	Buy	43,504,612 +617,429	+1%	+$27.1M	0.39%	41
2013 Q2	$1.92B	Buy	+42,887,183	New	+$1.86B	0.39%	40

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Institutional Trust's BMY Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q4 2016, selling an estimated $49.7M and leaving 46,068,321 shares worth $2.69B. The position accounts for 0.4% of the portfolio, ranked #41.

BlackRock Institutional Trust first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.27B in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

BlackRock Institutional Trust held 46,068,321 shares of Bristol-Myers Squibb worth $2.69B as of Q4 2016.
BlackRock Institutional Trust sold 908,927 Bristol-Myers Squibb shares in Q4 2016, an estimated $49.7M.
Bristol-Myers Squibb made up 0.4% of BlackRock Institutional Trust's portfolio in Q4 2016, its #41 holding.
BlackRock Institutional Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Bristol-Myers Squibb position peaked at $3.27B in Q2 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.